supported by grants from the National Natural Science Foundation of China(30572155);Zhejiang Provincial Natural Science Foundation of China(R206060).
BACKGROUND: Hepatocellular carcinoma (HCC) which is always refractory to most chemotherapeutic agents may result in poor survival of patients with advanced HCC. Oncolytic adenovirus is a new form for cancer gene thera...